CN108314690B - The metal complex and its synthetic method of double cup [4] arene derivatives and application - Google Patents

The metal complex and its synthetic method of double cup [4] arene derivatives and application Download PDF

Info

Publication number
CN108314690B
CN108314690B CN201810215041.0A CN201810215041A CN108314690B CN 108314690 B CN108314690 B CN 108314690B CN 201810215041 A CN201810215041 A CN 201810215041A CN 108314690 B CN108314690 B CN 108314690B
Authority
CN
China
Prior art keywords
cup
arene
formula
complex
double
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201810215041.0A
Other languages
Chinese (zh)
Other versions
CN108314690A (en
Inventor
刘元忠
唐玉国
刘涛
董文飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Guoke medical technology development (Group) Co., Ltd
Suzhou Institute of Biomedical Engineering and Technology of CAS
Original Assignee
Suzhou Institute of Biomedical Engineering and Technology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Institute of Biomedical Engineering and Technology of CAS filed Critical Suzhou Institute of Biomedical Engineering and Technology of CAS
Priority to CN201810215041.0A priority Critical patent/CN108314690B/en
Publication of CN108314690A publication Critical patent/CN108314690A/en
Application granted granted Critical
Publication of CN108314690B publication Critical patent/CN108314690B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18—Metal complexes
    • C09K2211/182—Metal complexes of the rare earth metals, i.e. Sc, Y or lanthanide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6432—Quenching

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)

Abstract

The invention discloses a kind of metal complexs of double cup [4] arene derivatives, have the chemical structure as shown in Formula II.Above-mentioned complex small toxicity, biocompatibility are high, suitable for the biomolecule covalent bond such as nucleic acid, peptide or protein, form the fluorescent probe molecule that fluorescent quantum rate is high, fluorescence lifetime is long, detection limit is low, suitable for the biomolecule detection in cell, tissue or living body, it is with a wide range of applications in biomedicine field.The invention discloses the synthetic methods of above-mentioned complex, provide multiple choices approach for the synthesis of complex, and synthesis path is simple and easy, and complex yield obtained is high, are adapted for engagement with the large-scale production preparation of object.

Description

The metal complex and its synthetic method of double cup [4] arene derivatives and application
Technical field
The invention belongs to technical field of biomedical detection, and in particular to a kind of double cup [4] arene derivatives and its metal Complex, synthetic method and application.
Background technique
Molecular recognition is main body (receptor) to object (substrate) selective binding and generates the process of specific function.It identified Journey may cause the variation of the magnetism, electricity, optical property and conformation of system, so as to cause chemical information storage, transmitting with And processing.Therefore, molecular recognition plays an important role in information processing transmitting, molecule and supermolecule device fabrication process.
It is main at present for causing magnetic or fluorescence property change to carry out molecular recognition using the combination of Subjective and Objective molecule Research direction, the extraction and separation of ion, bioanalysis, environmental project, material science and medicine etc. it is multi-field have extensively Application.Wherein, Fluorometric assay of fluorescence-labeled is a key area of molecular recognition, and fluorescence probe is established in molecular recognition and fluorescence It is a kind of molecule that molecular recognition process can be passed through to fluorescence signal effective expression, it is widely used in sun on the basis of technology The fluorescence identifying of the plurality of target substance such as ion, anion and neutral molecule detects.Fluorescent probe molecule is usually by recognition group It is formed with fluorophor two parts, recognition group decision realizes molecule by selective binding to the selectivity of different objects It identifies and obtains the information of molecule；Molecule combining information is converted to by the fluorescence signal transmission mechanism of phase fluorophor therewith It is easy to the fluorescence signal detected, to realize real-time detection in situ on a molecular scale.
In order to further increase the combination stability of subject and object molecule, selectivity in molecular recognition, new point is found The host molecule of son identification has become a hot topic of research.Calixarenes (calixarenes) as a kind of Novel macrocyclic compound, be by A kind of cyclic oligomer that phenol units are connected by methylene, because it exactly likes Greece sage by what aromatic ring was woven into Cup, therefore it is named as calixarenes.Calixarenes has synthesis material cheap and easy to get, and conformation is variable in a solvent, has unique space The advantages that structure, cavity size are adjustable, can form host-guest complex with cation, anion and neutral molecule；It can be with Guest molecule, therefore, calixarenes are identified by means of non-covalent bond effects such as hydrogen bond, electrostatic interaction, molecular force, pi accumulations " third generation host molecule " that has more potential for development being counted as after supramolecular chemistry relaying crown ether and cyclodextrin.
Talanova et al. reports the Hg based on cup [4] arene derivatives2+Chemical sensor.Wherein, cup [4] aromatic hydrocarbons spreads out Biology is to obtain the Derivatives Modified of naphthalene sulfonylamide on cup [4] aromatic hydrocarbons, and molecular structure is as follows:
The chloroformic solution of cup [4] arene derivatives has strong fluorescence at 520nm, and Hg is added2+Afterwards, cup [4] aromatic hydrocarbons spreads out Biological selectivity identifies Hg2+, and occur from sulfuryl amine group to Hg2+Electronics transfer, greatly reduce its fluorescence intensity, it is real Existing optical detection.But above-mentioned cup [4] arene derivatives selective binding Hg2+, it is imaged based on principle of fluorescent quenching, is examined in fluorescence There are background signals when survey it is big, sensitivity is lower the disadvantages of, be unsuitable for the biomolecule such as labeling nucleic acid or albumen for biological sample The detection of product limits its application in field of biomedicine.
Summary of the invention
Therefore, the technical problem to be solved by the present invention is to cup in the prior art [4] arene derivatives bind metal ions Have the defects that sensitivity is lower in fluorescence detection, be unsuitable for marking biomolecule, so that it is higher to provide a kind of sensitivity, fits In the metal complex of double cups [4] arene derivatives of biomolecular labeling.
For this purpose, having and being tied as shown in Formula II the present invention provides a kind of metal complex of double cup [4] arene derivatives Structure:
Wherein, M is rare earth ion；
R1~R8Separately it is selected from-H ,-NH2、-COOH、-CH2COOH、-CONH(CH2)XNH2、-CONH2、-SH、- CH2SH、-SO3H、 -SO3R、-NHCO(CH2)XCOOH、-NO2、-CH2PO(OH)2、 R is alkali metal or benzene, R1~R8It is not simultaneously-H, the integer that X is 0~3；
A is selected from-(CH2-CH2)n-、-(CH2OCH2)n-、-CONH(CH2)nNHCO- andN be 1~ 3 integer.
Preferably, the metal complex of above-mentioned double cups [4] arene derivatives, the rare earth metal are terbium or europium.
It is further preferred that the metal complex of above-mentioned double cups [4] arene derivatives, double cup [4] aromatic hydrocarbons are derivative The metal complex of object be selected from II-1~II-51 it is any shown in chemical structure:
The present invention provides a kind of synthetic methods of the metal complex of above-mentioned double cups [4] arene derivatives, including with Lower step:
(1) cup [4] arene compounds shown in cup [4] arene compounds shown in formula E and formula E ' are synthesized；Formula E ' institute Cup [4] arene compounds shown obtain intermediate shown in formula F ' through condensation reaction, introducing-O-A- group；
Wherein, R1'~R8' separately it is selected from-CHO ,-CH2CHO、-NHCO(CH2)XCHO、-SO3R、-H、-NH2、- CONH(CH2)XNH2、-CONH2、-SH、-CH2SH、-NO2、-CH2PO(OH)2、R is Alkali metal or benzene, the integer that X is 0~3, R1'~R8' it is not simultaneously-H；
TsO- is p-methyl benzenesulfonic acid base；
(2) intermediate shown in formula F ' is dissolved in the first organic solvent, p-methyl benzene sulfonic chloride is added, it is anti-at 0~4 DEG C It answers, after reaction pours into reaction solution in acid, precipitating, cup [4] arene compounds shown in as formula F are precipitated；
(3) [4] arene compounds of cup shown in formula E and alkali metal salt are dissolved in the second organic solvent, F is added after mixing Shown in cup [4] arene compounds, then second organic solvent is changed to third by the back flow reaction at 75~80 DEG C Organic solvent continues back flow reaction, filters after reaction, and the crystal in filtrate is precipitated；
(4) work as R1'~R8' it does not include-CHO ,-CH2CHO、-NHCO(CH2)XCHO and-SO3It is obtained in step (3) when R Crystal is double cup [4] arene derivatives shown in Formulas I；
Work as R1'~R8' in include at least one-CHO ,-CH2CHO、-NHCO(CH2)XCHO and/or-SO3When R, step (3) In the crystal obtained intermediate shown in ' shown in intermediate, by Formulas I ' that is Formulas I after peroxidating and/or hydrolysis, Formulas I is made Shown in double cup [4] arene derivatives；
(5) in an inert atmosphere, after rare earth metal salt being mixed with the 4th organic solvent that dehydration and deoxidation is handled It flows back at 75~80 DEG C, double cup [4] arene derivatives shown in Formulas I is then added, continues back flow reaction, cools down after reaction Reaction product filters, the metal complex of double cup [4] arene derivatives shown in isolated Formula II；
Synthetic route is as follows:
The present invention provides a kind of synthetic methods of the metal complex of above-mentioned double cups [4] arene derivatives, including with Lower step:
S1. cup [4] arene compounds shown in cup [4] arene compounds shown in formula E and formula E ' are synthesized；Wherein, R1'~R8' separately it is selected from-CHO ,-CH2CHO、-NHCO(CH2)XCHO、-SO3R、-H、-NH2、-CONH(CH2)XNH2、-CONH2、-SH、-CH2SH、-NO2、 -CH2PO(OH)2、R be alkali metal or Benzene, the integer that X is 0~3, R1'~R8' it is not simultaneously-H；
S2. by cup [4] arene compounds and alkali metal salt shown in cup shown in formula E [4] arene compounds, formula E ' It mixes, is dissolved in the 5th organic solvent, continuously adds compound TsO-A-OsT, under inert gas protection, at 110-125 DEG C Back flow reaction, cooled reaction solution, post separation obtain reaction product after reaction；Wherein, TsO- is p-methyl benzenesulfonic acid base；
S3. work as R1'~R8' it does not include-CHO ,-CH2CHO、-NHCO(CH2)XCHO and-SO3It is obtained in step S2 when R Reaction product is intermediate shown in Formulas I；
Work as R1'~R8' in include at least one-CHO ,-CH2CHO、-NHCO(CH2)XCHO and/or-SO3When R, step S2 In the reaction product obtained intermediate shown in ' shown in intermediate, by Formulas I ' that is Formulas I after peroxidating and/or hydrolysis, be made Double cup [4] arene derivatives shown in Formulas I；
S4. in an inert atmosphere, after rare earth metal salt being mixed with the 4th organic solvent that dehydration and deoxidation is handled It flows back at 75~80 DEG C, double cup [4] arene derivatives shown in Formulas I is then added, continue back flow reaction, it is cold after reaction But reaction product filters, the metal complex of double cup [4] arene derivatives shown in isolated Formula II；
Synthetic route is as follows:
Preferably, above-mentioned synthetic method, first organic solvent are pyridine, and second organic solvent is acetonitrile, The third organic solvent is second alcohol and water with the mixed solution of the volume ratio of 1:1, and the 4th organic solvent is acetonitrile, described Alkali metal salt is potassium carbonate.
Preferably, above-mentioned synthetic method, the 5th organic solvent are toluene.
Preferably, above-mentioned synthetic method, cup shown in cup [4] arene compounds and the formula F shown in the formula E [4] molar ratio of arene compounds is 3:2~1:1, double cup [4] arene derivatives shown in the Formulas I and rare earth gold The molar ratio for belonging to salt is 1:1~2:3, the molar ratio of cup [4] arene compounds and the alkali metal salt shown in the formula E For 1:5.
Preferably, above-mentioned synthetic method, cup shown in cup [4] arene compounds, the formula E ' shown in the formula E [4] molar ratio of arene compounds, the compound TsO-A-OsT and the alkali metal salt is (2~3): (2~3): (2.5 ~3): (12.5~20).
Purposes the present invention provides the metal complex of above-mentioned double cups [4] arene derivatives as fluorescent dye.
The present invention provides a kind of fluorescent probe molecule, the fluorescent probe molecule is the biology point of fluorochrome label Son, the fluorescent dye be above-mentioned double cups [4] arene derivatives metal complex, the biomolecule selected from amino acid, At least one of polypeptide, albumen, nucleotide, oligonucleotides and nucleic acid.
Preferably, above-mentioned fluorescent probe molecule, the nucleotide, oligonucleotides and nucleic acid are amido modified nucleosides Acid, oligonucleotides and nucleic acid.
Preferably, above-mentioned fluorescent probe molecule, the metal complex of double cup [4] arene derivatives is in bridging agent In the presence of, it is connected with any group in the amino of the biomolecule, carboxyl and sulfydryl.
It is further preferred that above-mentioned fluorescent probe molecule, the bridging agent is n-hydroxysuccinimide, N- hydroxyl sulphur For succinimide salt, maleimide, glutaraldehyde or carbodiimide.
Above-mentioned technical proposal of the invention has the advantage that
1. the metal complex of double cups [4] arene derivatives provided by the invention has the structure as shown in Formula II.
Complex shown in Formula II is to be bonded based on double cups [4] arene derivatives I by object of rare earth ion Made of inclusion complex, wherein double cups [4] arene derivatives I is by two one cup [4] arene derivatives respectively by the hydroxyl of lower edge Base is connected double cups [4] aromatic hydrocarbons of four bridgings to be formed with bridging unit A, and A is separately selected from-(CH2-CH2)n-、- (CH2OCH2)n-、-(CH2PhCH2)nAnd-CONH (CH2)nThe integer that NHCO-, n are 1~3.Above-mentioned double cups [4] aromatic hydrocarbons is derivative Object conformational stability, double cup [4] arene derivatives form three-dimensional tube cavity at bridging position, in entrance tube cavity Metal ion forms space limit；On the one hand bridge linkage group A forms the mating reaction to metal ion using non-covalent bond, another Aspect can be adjusted the size of three-dimensional tube cavity, by adjusting bridge linkage group A to be formed to special metal ion Position-limiting action.Synergistic effect by space limit with non-covalent bond cooperation between the two, makes double cups of structure shown in Formulas I [4] arene derivatives Selective recognition rare earth ion, and there is excellent mating capability.
The complex that double cup [4] arene derivatives selective complexation rare earth ions are formed has good water solubility, toxicity It is small, can be compatible with living cells etc. advantages.Meanwhile R1~R8Substituent group can be condensed by amidation or sulfuryl amine etc. The biomolecule covalent bond such as reaction and nucleic acid, albumen, polypeptide, obtains the conjugate of complex and biomolecule, with realization pair External, the detection of intracellular or biological living of specific protein, DNA molecular. R1~R8Amido bond in substituent group can increase Add double cup [4] arene derivatives to the selection Complex effect of rare earth ion, to improve complex as biomolecule detection The detection effect of probe.
Double cup [4] arene derivatives selective complexation rare earth ions make rare earth ion enter double cup [4] aromatic hydrocarbons In the three-dimensional tube cavity of derivative, the complex of conformational stability is formed.Energy in complex is transmitted by rare earth ion To double cup [4] arene derivatives, make double cup [4] arene derivatives that energy level transition occur, it finally will in the form of fluorescent photon Amount releases, and complex is made to generate characteristic fluorescence.Amide groups, carbonyl in double cup [4] aromatic hydrocarbons,Etc. structures be beneficial to further increase calixarenes to dilute The ability of earthmetal cations absorbs, and carries out effective transmitting of energy, makes finally with the fluorescence volume of the fluorescence probe of complex preparation Sub- yield height, fluorescence lifetime length, detection limit are low, luminosity is stablized, and can be realized long-time, real-time, dynamic METHOD FOR CONTINUOUS DETERMINATION.Separately Outside, due to fluorescence probe have it is preferable water-soluble, stable in physiological conditions, it is good to cell membrane penetration, and to cell toxicant Property it is small, be suitable for active somatic cell detect.
2. the present invention provides the synthetic method of the metal complex of two kinds of double cup [4] arene derivatives, mentioned for complex II Various selectable synthesis path is supplied, and synthesis process is simple and easy, it is cheap and easy to get to synthesize required raw material, with above two The yield that method prepares complex II is high, is suitable for large-scale industrial production and prepares.
The present invention provides the raw material proportioning for the metal complex for being suitable for double cup [4] arene derivatives of high yield and synthesis items Part can reduce cup [4] arene compounds and compound TsO-A- shown in cup shown in formula E [4] arene compounds, formula E ' Cup [4] arene compounds are in condensation reaction shown in cup [4] arene compounds and formula F shown in OsT or formula E Mispairing combine, improve the yield of double cup [4] arene derivatives I.
3. fluorescent probe molecule provided by the invention, wherein fluorescent probe molecule is the biomolecule of fluorochrome label, Fluorescent dye be above-mentioned double cups [4] arene derivatives metal complex, biomolecule selected from amino acid, polypeptide, albumen, At least one of nucleotide, oligonucleotides and nucleic acid.Above-mentioned fluorescent probe molecule (example in conjunction with object to be measured molecular specificity If object to be measured molecule is antigen, then biomolecule is the antibody specifically bound therewith), then by fluorescence detection to obtain Object to be measured molecular information.Since the metal complex that double cups [4] arene derivatives and rare earth ion are formed has both fluorescence The advantage that yield is high, fluorescence lifetime is long, fluorescence property is stablized and small toxicity, cell membrane penetration are good and bio-compatibility is high, It can be widely applied to the detection of intraor extracellular substance, tissue and the imaging of living animal label, Pharmaceutical Analysis, pathological model research and disease Disease early diagnosis etc., it is with important application prospects in field of biomedical research.
Detailed description of the invention
It, below will be to specific in order to illustrate more clearly of the specific embodiment of the invention or technical solution in the prior art Embodiment or attached drawing needed to be used in the description of the prior art be briefly described, it should be apparent that, it is described below Attached drawing is some embodiments of the present invention, for those of ordinary skill in the art, before not making the creative labor It puts, is also possible to obtain other drawings based on these drawings.
Fig. 1 is the nuclear magnetic resonance figures of double cups [4] arene derivatives I-1 in the embodiment of the present invention 1；
Fig. 2 is the testing result of the fluorescence spectrum of complex II-1 in experimental example 1 of the present invention；
Fig. 3 is the testing result of the fluorescence spectrum of complex II-2 in experimental example 1 of the present invention；
Fig. 4 is the testing result of the fluorescence spectrum of complex II-3 in experimental example 1 of the present invention；
Fig. 5 is the testing result of the fluorescence spectrum of complex II-4 in experimental example 1 of the present invention；
Fig. 6 is that the complex II-1 of various concentration in experimental example 2 of the present invention is growth inhibiting to prostate gland cancer cell PC-3 Testing result figure；
Fig. 7 is that the complex II-2 of various concentration in experimental example 2 of the present invention is growth inhibiting to prostate gland cancer cell PC-3 Testing result figure；
Fig. 8 is that the complex II-3 of various concentration in experimental example 2 of the present invention is growth inhibiting to prostate gland cancer cell PC-3 Testing result figure；
Fig. 9 is that the complex II-4 of various concentration in experimental example 2 of the present invention is growth inhibiting to prostate gland cancer cell PC-3 Testing result figure；
Figure 10 is shown in experimental example 3 of the present invention marks EGFR antibody to detect cancer as fluorescent probe molecule using complex II-1 The fluorescence imaging result figure that EGFR is expressed in disease cell；
Figure 11 shows complex II-1~fluorescent stability of the complex II-4 as fluorescent dye in experimental example 5 of the present invention Testing result figure.
Specific embodiment
Technical solution of the present invention is clearly and completely described below in conjunction with attached drawing, it is clear that described implementation Example is a part of the embodiment of the present invention, instead of all the embodiments.Based on the embodiments of the present invention, ordinary skill Personnel's every other embodiment obtained without making creative work, shall fall within the protection scope of the present invention. In addition, technical characteristic involved in invention described below different embodiments is as long as they do not conflict with each other It can be combined with each other.
The basic chemical industries raw material such as reagent used in the embodiment of the present invention chemical products can be commercially available at home, or Related intermediate preparation factory is customized.
Embodiment 1
The present embodiment provides a kind of metal complex and preparation method thereof of double cup [4] arene derivatives, double cup [4] aromatic hydrocarbons Derivative has the molecular structure as shown in Formulas I -1；Double cup [4] arene derivatives and rare earth ion Tb3+Matched Object is closed, molecular structure is as shown in Formula II -1:
With intermediate E -1 and intermediate F-1 synthetic intermediate I ' -1, double cup [4] aromatic hydrocarbons are obtained after the oxidation of intermediate compound I ' -1 Derivative I -1, double cup [4] arene derivatives I-1 complex rare-earth metal ion Tb3+, obtain double cup [4] arene derivatives I-1 with Tb3+Complex II-1, synthetic route are as follows:
(1) preparation of intermediate E -1
Step 1: using cup [4] aromatic hydrocarbons as reaction raw materials, taking cup [4] aromatic hydrocarbons (30.0g/70.7mmol), Anhydrous potassium carbonate (10.7g/77.4mmol) and p-methyl benzenesulfonic acid methyl esters (26.3g/141.4mmol), is dissolved in the CH of 500mL3It flows back in CN For 24 hours, it drains, the CH of 500mL is then added2Cl2And be added 1mol/L HCl (2 × 50mL), salt water 50mL, solvent is removed, is taken out It is dry, product I-1-1 is obtained after dry:
Step 2: taking compound I-1-1 (5.00g, 9.83mmol), NaH (1.60g, 39.30mmol, with 60% quality Score suspend in the oil), stir 30min after being dissolved in the DMF of 200mL, then be added 4-Nitrobenzenesulfonyl chloride (8.71g, 39.30mmol), it reacts at room temperature 7 days and obtains compound I-1-2:
Step 3: by compound I-1-2 (0.5g, 0.57mmol), hexamethylenetetramine (2.87g, 20.00mmol) is dissolved in In 30mL trifluoroacetic acid, 22h is reacted under -80 DEG C, nitrogen protection, obtains compound I-1-3, ethyl alcohol of the compound I-1-3 in KOH The 12h that flows back in solution obtains compound I-1-4.
The nuclear-magnetism characterize data of compound I-1-4:1H-NMR(CDC13) 8.23 (s, 2H, CHO), 7.28 (s, 4H, Ar), 6.91 (s, 6H, Ar), 5.99 (s, 4H, OH), 3.81 (s, 8H, CH2)。
Mass spectrum mlecalcd 480.14, found (M-H+)481.20。
Step 4: by compound I-1-4 (1.0mmol), the tetrahydrofuran solution containing 1mol/L tetrabutylammonium fluoride 0.0044mL, 4.4mmol acetic acid react at room temperature 3h in the DMF of 7.2mL；Then it is added into reaction mixture The HCl of 1.2mol/L, solution layering, is extracted with chloroform, and revolving is dried to get intermediate E -1, yield 90%:
The nuclear-magnetism characterize data of intermediate E -1:1H-NMR(CDC13) 8.23 (s, 2H, CHO), 7.28 (s, 4H, Ar), 6.91 (s, 6H, Ar), 5.99 (s, 4H, OH), 3.81 (s, 8H, CH2)。
Mass spectrum mlecalcd 480.14, found (M-H+)481.20。
(2) preparation of intermediate F-1
Step 5: intermediate E -1 being dissolved in the ether of 250mL, is added LiAlH4 (11.5mmol), was reacted at 0 DEG C Night continues the HCl that 2mol/L is slowly added into reaction solution, and precipitating is precipitated, and removes ether, the isolated compound I- of chromatography 1-5, yield: 86%:
Step 6: at a temperature of 0 DEG C, compound I-1-5 (1.2mmol) being dissolved in the pyridine of 25ml, is then added to first Base benzene sulfonyl chloride (14.5mmol) saves 4 days in 4 DEG C of refrigerators, and solution pours into the HCl of 250mL 2mol/L frost, is precipitated Precipitating filters, and collects, dry intermediate F-1:
The nuclear-magnetism characterize data of intermediate F-11H-NMR(CDC13) 8.23 (s, 2H, CHO), 8.0-7.84 (d, 8H, Ar), 7.78 (d, 8H, Ar), 7.55 (s, 4H, Ar), 7.38 (s, 4H, Ar), 4.77 (s, 2H, PhOH), 3.81 (m, 1H, CH2), 1.28,1.11 (s, 36H, C (CH3)3)。
Mass spectrum mlecalcd 1400.25, found (M-H+) 1401.21.
(3) preparation of intermediate compound I ' -1
Intermediate E -1 (0.7mmol) and potassium carbonate (3.5mmol) are dissolved in acetonitrile, then intermediate is added in stirring 2h F-1 (0.7mmol) flows back 5 days at 78 DEG C, and after vacuum pump removes solvent, the second of 1:1 (v:v) is added into solid matter Then alcohol-water mixtures dissolution, suspension heated overnight at reflux filter while hot, crude product is dissolved in 50mL chloroform, then with filter Limpid solution is obtained by filtration in paper, is then added the acetone of 40mL, intermediate compound I is precipitated to obtain in crystal ' -1, yield 71%:
The nuclear-magnetism characterize data of intermediate compound I ' -1:1H-NMR(CDC13) 9.9,9.7 (s, 4H, CHO), 7.54-7.16 (m, 20H, Ar), 4.36 (d, 16H, PhOCH2CH2), 3.81 (s, 16H, PhCH2)。
Mass spectrum mlecalcd 1064.38, found (M-H+)1065.45。
(4) double cup [4] arene derivatives I-1, double cups [4] arene derivatives I-1 and Tb3+Complex II-1 preparation
Intermediate compound I ' -1 is dissolved in acetonitrile, and it is derivative up to double cup [4] aromatic hydrocarbons that suitable trifluoroacetic acid (TFA) reaction 2h is added Under argon gas protective condition, TbCl is added into the 100mL two mouth flask of dehydration and deoxidation in object I-13With the processed second of dehydration and deoxidation The acetonitrile solution of double cup [4] arene derivatives I-1 is added dropwise into the white suspension after half an hour of flowing back at 75 DEG C for nitrile, TbCl3Molar ratio with compound I-1 is 1.2:1, reacts 4h.Cooled reaction solution after reaction, filtering, HPLC are separated To double cups [4] arene derivatives I-1 and Tb3+Complex II-1:
Embodiment 2
The present embodiment provides the synthetic methods of the metal complex II-1 of double cup [4] arene derivatives a kind of:
With intermediate E -1, intermediate E ' -1 (being equal to intermediate E -1) and TsO-CH2-CH2- OsT synthetic intermediate I '- 1, obtain double cup [4] arene derivatives I-1 after the oxidation of intermediate compound I ' -1, double cup [4] arene derivatives I-1 complex rare-earth metals from Sub- Tb3+, obtain double cup [4] arene derivatives I-1 and Tb3+Complex II-1, synthetic route are as follows:
(1) preparation of intermediate E -1
For synthesis process with the synthesis of the intermediate E -1 of embodiment 1, intermediate E ' -1 and intermediate E -1 are same compound.
(2) preparation of intermediate compound I ' -1
By intermediate E -1 (0.8mmol), intermediate E ' -1 (1mmol) and K2CO3(7mmol) is dissolved in toluene, then plus Enter TsO-CH2-CH2- OsT (1.1mmol), under nitrogen protection, flow back 2h at a temperature of 110 DEG C, is then added a certain amount of Polyethylene glycol, then flow back 2 days, cooling, the isolated intermediate compound I of silicagel column ' -1, yield 67%:
(3) double cup [4] arene derivatives I-1, double cups [4] arene derivatives I-1 and Tb3+Complex II-1 preparation
Intermediate compound I ' -1 is dissolved in acetonitrile, and it is derivative up to double cup [4] aromatic hydrocarbons that suitable trifluoroacetic acid (TFA) reaction 2h is added Under argon gas protective condition, TbCl is added into the 100mL two mouth flask of dehydration and deoxidation in object I-13With the processed second of dehydration and deoxidation The acetonitrile solution of double cup [4] arene derivatives I-1 is added dropwise into the white suspension after 80 DEG C of reflux half an hours for nitrile, TbCl3Molar ratio with compound I-1 is 1:1, reacts 4h.Cooled reaction solution after reaction, filtering, HPLC are isolated Double cup [4] arene derivatives I-1 and Tb3+Complex II-1:
Embodiment 3
The present embodiment provides a kind of metal complex and preparation method thereof of double cup [4] arene derivatives, double cup [4] aromatic hydrocarbons Derivative has the molecular structure as shown in Formulas I -2；Double cup [4] arene derivatives and rare earth ion Eu3+Matched Object is closed, molecular structure is as shown in Formula II -2:
It is synthesized with intermediate E -2 and intermediate F-2 (intermediate shown in formula F-2 is equal to intermediate shown in formula F-1) Intermediate compound I ' -2 obtain double cup [4] arene derivatives I-2, double cup [4] arene derivatives I-2 complexings after the oxidation of intermediate compound I ' -2 Rare earth ion Eu3+, obtain double cup [4] arene derivatives I-2 and Eu3+Complex II-2, synthetic route are as follows:
(1) preparation of intermediate E -2
Step 1: using cup [4] aromatic hydrocarbons as reaction raw materials, taking cup [4] aromatic hydrocarbons (30.0g/70.7mmol), Anhydrous potassium carbonate (10.7g/77.4mmol), p-methyl benzenesulfonic acid methyl esters (26.3g/141.4mmol), is dissolved in the CH of 500mL3It flows back in CN for 24 hours, It drains, the CH of 500mL is then added2Cl2And be added 1mol/L HCl (2 × 50mL), salt water 50mL, solvent is removed, is drained, is done Product I-1-1 is obtained after dry:
Step 2: taking compound I-1-1 (5.00g, 9.83mmol), NEH (1.60g, 39.30mmol, with 60% quality Score suspend in the oil), stir 30min after being dissolved in the DMF of 200mL, then be added 4-Nitrobenzenesulfonyl chloride (8.71g, 39.30mmol), it reacts at room temperature 7 days and obtains compound I-1-2:
The nuclear-magnetism characterize data of compound I-1-2:1H-NMR(CDC13) 8.34 (d, 4H, Er), 7.91 (m, 4H, Er), 7.7 (d, 6H, Er), 6.91 (m, 6H, Er), 3.81 (d, 14H, CH2, CH3), 1.2 (s, 2H, OH).
Mass spectrum mlecElcd 822.16, found (M-H+)823.17。
Step 3: compound I-1-2 (1.14mmol) is dissolved in 100mL methylene chloride and 12mL acetum, continues thereto The nitric acid of 4mL is added dropwise, reacts at room temperature 48h, is poured into water, then with the CH of 3 × 100mL2Cl2Extraction removes solvent and obtains compound I-2-1, yield 83%:
The nuclear-magnetism characterize data of compound I-2-1:1H-NMR(CDC13) 8.34 (d, 4H, Er), 8.02 (m, 4H, Er), 7.91 (d, 4H, Er), 6.91 (m, 6H, Er), 3.81 (d, 14H, CH2,CH3), 1.2 (s, 2H, OH).
Mass spectrum mlecElcd 822.16, found (M-H+)823.17。
Step 4: compound I-2-1 (1.0mmol), 1mol/L tetrabutylammonium fluoride tetrahydrofuran solution 0.0044mL with 4.4mmol acetic acid is mixed in jointly in the DMF of 7.2mL, reacts at room temperature 3h.Continue to be added 1.2mol/L's to reaction mixture HCl, solution layering, is extracted with chloroform, rotates dry compound I-2-2, yield 93%:
The nuclear-magnetism characterize data of compound I-2-2:1H-NMR(CDC13) 8.17 (d, 4H, Er), 7.24~6.77 (m, 6H, Er), 3.81 (d, 14H, CH2,CH3), 0.62 (s, 2H, OH).
Mass spectrum mlecElcd 542.16, found (M-H+)543.27。
Step 5: to catalyst nickel is added in compound I-2-2 (0.67mmol), being dissolved in the methanol containing 1.5mL hydrazine hydrate In (100mL) solution, reflux 7h is added, the hydrazine hydrate and catalyst nickel for adding 1.5mL continue the 15h that flows back, are cooled to room temperature, Filtering, chromatography separation, obtains compound I-2-3:
The nuclear-magnetism characterize data of intermediate compound I -2-3:1H-NMR(CDC13) 8.52 (s, 2H, OH), 7.16 (d, 4H, Er), 6.9 (m, 2H, Er), 6.68 (d, 4H, Er), 4.09 (s, 4H, NH2), 3.86 (s, 6H, CH3), 3.81 (s, 8H, CH2)；
Mass spectrum mlecElcd 482.22, found (M-H+)483.26。
Step 6: by compound I-2-3 (1.0mmol), the tetrahydrofuran solution containing 1mol/L tetrabutylammonium fluoride 0.0044mL and 4.4mmol acetic acid reacts at room temperature 3h in the DMF of 7.2mL.Then, it is added to reaction mixture The HCl of 1.2mol/L, solution layering, is extracted with chloroform, rotates dry intermediate E -2, yield 90%:
The synthesis characterization data of intermediate E -2:1H-NMR(CDC13) 7.15 (d, 4H, Er), 6.93 (d, 2H, Er), 6.52 (s, 4H, Er), 3.93 (s, 4H, NH2), 3.81 (s, 8H, CH2)。
Mass spectrum mlecElcd 482.22, found (M-H+)483.26。
(2) preparation of intermediate F-2
The intermediate F-1 prepared in intermediate F-2 and embodiment 1 is same substance.
(3) preparation of intermediate compound I ' -2
Intermediate E -2 (0.84mmol), potassium carbonate (4.2mmol) are dissolved in acetonitrile, then intermediate F-2 is added in stirring 2h (0.7mmol), 80 DEG C are flowed back 5 days, and vacuum pump removes solvent, and the solid matter ethanol-water mixture of 1:1 (V:V) is dissolved, Suspension heated overnight at reflux, reflux temperature are 78 DEG C, are then filtered while hot, and crude product is dissolved in 50mL chloroform, then with filter Limpid solution is obtained by filtration in paper, is then added the acetone of 40mL, intermediate compound I is precipitated to obtain in crystal ' -2, yield 68%:
The nuclear-magnetism characterize data of intermediate compound I ' -2:1H-NMR(CDC13) 7.84-6.50 (m, 22H, Er), 4.36 (d, 16H, PhOCH2CH2), 4.14 (s, 2H, PhCH2), 3.81 (s, 12H, CH2), 3.55 (s, 2H, CH2), 2.58 (m, 2H, CH2), 1.54 (s, 18H, C (CH3)3)。
Mass spectrum mlecElcd 1352.60, found (M-H+)1353.21。
(4) double cup [4] arene derivatives I-2, double cups [4] arene derivatives I-2 and Eu3+Complex II-2 preparation
Intermediate compound I ' -2 are dissolved in acetonitrile, and it is derivative up to double cup [4] aromatic hydrocarbons that suitable trifluoroacetic acid (TFA) reaction 2h is added Under argon gas protective condition, EuCl is added into the 100mL two mouth flask of dehydration and deoxidation in object I-23With the processed second of dehydration and deoxidation Nitrile.It is flowed back after half an hour at 80 DEG C, the acetonitrile solution of double cup [4] arene derivatives I-2 is added dropwise into the white suspension, EuCl3Molar ratio with compound I-2 is 1.5:1, reacts 5h.Cooled reaction solution after reaction, filtering, HPLC are separated To double cups [4] arene derivatives I-2 and Eu3+Complex II-2:
Embodiment 4
The present embodiment provides the synthetic methods of the metal complex II-2 of double cup [4] arene derivatives a kind of:
With intermediate E -2, intermediate E ' -2, (intermediate shown in intermediate shown in formula E ' -2 and formula E-1 is same object Matter) and TsO-CH2-CH2- OsT synthetic intermediate I ' -2 obtain double cup [4] arene derivatives I-2 after the oxidation of intermediate compound I ' -2, Double cup [4] arene derivatives I-2 complex rare-earth metal ion Eu3+, obtain double cup [4] arene derivatives I-2 and Eu3+Cooperation Object II-2, synthetic route are as follows:
(1) preparation of intermediate E -2
Synthesis of the synthesis process with the intermediate E -2 of embodiment 3.
(2) preparation of intermediate E ' -2
Preparation process of the synthesis process with the intermediate E -1 of embodiment 1.
(3) preparation of intermediate compound I ' -2
By intermediate E -2 (1.2mmol), intermediate E ' -2 (0.8mmol) and K2CO3(5mmol) is dissolved in toluene, then TsO-CH is added2-CH2- OsT (1mmol), under nitrogen protection, flow back 2h at a temperature of 125 DEG C, is then added a certain amount of Polyethylene glycol, then flow back 2 days, cooling, the isolated intermediate compound I of silicagel column ' -2, yield 70%:
(3) double cup [4] arene derivatives I-2, double cups [4] arene derivatives I-2 and Eu3+Complex II-2 preparation
Intermediate compound I ' -2 are dissolved in acetonitrile, and it is derivative up to double cup [4] aromatic hydrocarbons that suitable trifluoroacetic acid (TFA) reaction 2h is added Under argon gas protective condition, EuCl is added into the 100mL two mouth flask of dehydration and deoxidation in object I-23With the processed second of dehydration and deoxidation Nitrile.It is flowed back after half an hour at 75 DEG C, the acetonitrile solution of double cup [4] arene derivatives I-2 is added dropwise into the white suspension, EuCl3Molar ratio with compound I-2 is 1.2:1, reacts 5h.Cooled reaction solution after reaction, filtering, HPLC are separated To double cups [4] arene derivatives I-2 and Eu3+Complex II-2:
Embodiment 5
The present embodiment provides a kind of metal complex and preparation method thereof of double cup [4] arene derivatives, double cup [4] aromatic hydrocarbons Derivative has the molecular structure as shown in Formulas I -3；Double cup [4] arene derivatives and rare earth ion Eu3+Matched Object is closed, molecular structure is as shown in Formula II -3:
To obtain intermediate after intermediate E -3 and intermediate F-3 synthetic intermediate I ' -3-1, intermediate compound I ' -3-1 oxidation I ' -3-2, intermediate compound I ' -3-2 obtain double cup [4] arene derivatives I-3 through hydrolysis, and double cup [4] arene derivatives I-3 complexings are dilute Earthmetal cations Eu3+, obtain double cup [4] arene derivatives I-3 and Eu3+Complex II-3, synthetic route are as follows:
(1) preparation of intermediate E -3
Step 1: using cup [4] aromatic hydrocarbons as reaction raw materials, taking cup [4] aromatic hydrocarbons (30.0g/70.7mmol), Anhydrous potassium carbonate (10.7g/77.4mmol), p-methyl benzenesulfonic acid methyl esters (26.3g/141.4mmol), is dissolved in the CH of 500mL3It flows back in CN for 24 hours, It drains, the CH of 500mL is then added2Cl2And be added 1mol/L HCl (2 × 50mL), salt water 50mL, solvent is removed, is drained, is done Product I-1-1 is obtained after dry:
Step 2: compound I-1-1 (3.9mmol) is dissolved in the CH of 200mL2Cl2In the mixed liquor of the acetic acid of 2mL, then plus Enter the HNO of 0.5mL3, normal-temperature reaction 45min, the NaHCO being saturated with 150mL3Aqueous solution terminates reaction, continues to stir 10min, remove Solvent is removed, chromatography obtains compound I-3-1:
Step 3: compound I-3-1 (1.81mmol) is dissolved in the CHCl of 30mL3In, -13 DEG C are cooled to, is then added Cl2CHOCH3(5.43mmol) and SnCl43h is stirred at room temperature in (1.81mmol), then terminates reaction with the HCl of 1mol/L, after Continuous stirring 20min, then removes solvent, purification by chromatography obtains compound I-3-2:
Step 4: compound I-3-2 (1.72mmol), the tetrahydrofuran solution containing 1mol/L tetrabutylammonium fluoride 0.0044mL, 4.4mmol acetic acid react at room temperature 3h in the DMF of 7.2mL；Then it is added into reaction mixture The HCl of 1.2mol/L, solution layering, is extracted with chloroform, is rotated drying, is obtained compound I-3-3:
Step 5: hydrazine hydrate (8.36mmol) and catalyst Pd/C are added to the second containing 0.418mmol compound I-3-3 In alcohol (25mL) solution, 3h is reacted at 60 DEG C, in N2It is filtered to remove Pd/C catalyst under protection, removes solvent, purifyingization Object E-3 is closed, yield 76%:
(2) preparation of intermediate F-3
Step 5: p-sulfonic acid sodium cup [4] aromatic hydrocarbons (13.6mol) is dissolved in the ether of 250mL, and LiAlH4 is added (11.5mmol) stays overnight in 0 DEG C of reaction, the HCl of 2mol/L is slowly added into reaction solution, precipitating is precipitated, remove ether, chromatography The isolated compound I-3-4 of method, yield 86%:
The nuclear-magnetism characterize data of compound I-3-4:1H-NMR(CDC13) 7.28 (s, 4H, Ar), 6.91 (s, 4H, Ar), 3.81 (s, 8H, CH2), 3.78 (m, 8H, CH2)；
mass spectrum mlecalcd 920.12,found(M-H+)921.23。
Step 6: at a temperature of 0 DEG C, compound I-3-4 (1.2mmol) is dissolved in the pyridine of 25ml, is then added to methyl Benzene sulfonyl chloride (14.5mmol) then saves 4 days in 4 DEG C of refrigerators, and solution pours into the HCl of 250mL2mol/L frost, and there have to be heavy Precipitation goes out, and filtering collects precipitating, is dried to obtain intermediate F-3:
The nuclear-magnetism characterize data of intermediate F-3:1H-NMR(CDC13)7.98-7.33(d,24H,Ar),4.45(d,8H, CH2),3.95(d,8H,CH2),3.81(s, 8H,CH2),2.42(s,12H,CH3)；
mass spectrum mlecalcd1216.14,found(M-H+)1217.25。
(3) preparation of double cup [4] arene derivatives I-3
Intermediate E -3 (1.05mmol), potassium carbonate (5.25mmol) are dissolved in acetonitrile, then intermediate F- is added in stirring 2h 3 (0.7mmol) flow back 5 days at 80 DEG C, and vacuum pump removes solvent, and the solid matter alcohol-water of 1:1 (V:V) is mixed Then liquid dissolution, suspension heated overnight at reflux filter while hot, crude product is dissolved in 50mL chloroform, is then filtered with filter paper To limpid solution, the acetone of 40mL is then added, double cup [4] arene derivatives I ' -3-1 are precipitated to obtain in crystal, yield 81%:
The nuclear-magnetism characterize data of double cup [4] arene derivatives I ' -3-1:1H-NMR(CDC13)8.44-7.75(d,22H, Ar),7.30-6.66,(d,20H,Ar), 6.02-4.70(s,22H,CH2),4.17,3.96(d,12H,CH2),3.95(d,8H, CH2),3.81(m,8H,CH2),3.50-3.31(s,12H,CH2)；
mass spectrum mlecalcd1433.13,found(M-H+)1434.21。
Step 8: compound I ' -3-1 (1.72mmol) is dissolved in chloroform/acetone (60ml, 1/1, v/v), is cooled to 0 DEG C, so After H is added2NSO3H (545mg, 5.62mmol) and NaClO2(342mg, 3.78mmol) mixed liquor 15mL, is stirred at room temperature 18h, Solvent is removed, chromatography obtains compound I ' -3-2, yield 70%:
Step 9: compound I ' -3-2 (1.72mmol) being dissolved in acetonitrile, suitable trifluoroacetic acid is added, is stirred at room temperature 6h removes solvent, and dry, purifying obtains compound I-3:
The nuclear-magnetism characterize data of compound I-3:1H-NMR(CDC13) 8.44-7.75 (d, 22H, Ar), 7.30-6.66, (d, 20H, Ar), 6.02-4.70 (s, 22H, CH2), 4.17,3.96 (d, 12H, CH2), 3.95 (d, 8H, CH2), 3.81 (m, 8H, CH2), 3.50-3.31 (s, 12H, CH2)；
Mass spectrum mlecalcd 1331.23, found (M-H+)1332.25。
(4) double cup [4] arene derivatives I-3 and Eu3+Complex II-3 preparation
Under argon gas protective condition, a certain amount of EuCl is added into the 100mL two mouth flask of dehydration and deoxidation3And dehydration and deoxidation Double cup [4] arene derivatives I-3 are added dropwise into the white suspension after half an hour of flowing back at 80 DEG C for processed acetonitrile Acetonitrile solution, EuCl3Molar ratio with compound I-1 is 1.5:1.4h is reacted, cooling, filtering, the isolated double cups of HPLC [4] arene derivatives I-3 and Eu3+Complex II-3:
Embodiment 6
With intermediate E -3, intermediate E ' -3 (intermediate shown in formula E ' -3 is p-sulfonic acid sodium cup [4] aromatic hydrocarbons) and TsO- CH2-CH2- OsT synthesizes double cup [4] arene derivatives I ' -3-1, obtains double cups after double cup [4] arene derivatives I ' -3-1 oxidations [4] arene derivatives I ' -3-2, compound I ' -3-2 hydrolyze to obtain double cup [4] arene derivatives I-3, and compound I-3 complexing is dilute Earthmetal cations Eu3+, obtain double cup [4] arene derivatives I-3 and Eu3+Complex II-3, synthetic route are as follows:
(1) preparation of intermediate E -3
For synthesis process with the synthesis of the intermediate E -3 of embodiment 5, intermediate shown in formula E ' -3 is p-sulfonic acid sodium cup [4] aromatic hydrocarbons.
(2) preparation of intermediate compound I ' -3-1
By intermediate E -3 (1mmol), intermediate E ' -3 (1.2mmol) and K2CO3(8mmol) is dissolved in toluene, then plus Enter TsO-CH2-CH2- OsT (1.2mmol), under nitrogen protection, flow back 2h at a temperature of 120 DEG C, is then added a certain amount of Polyethylene glycol, then flow back 2 days, cooling, isolated the intermediate compound I ' -3-1 of silicagel column, yield 78%:
(4) double cup [4] arene derivatives I-3, double cups [4] arene derivatives I-3 and Eu3+Complex II-3 preparation
Synthesis process is the same as embodiment 5.
Embodiment 7
The present embodiment provides a kind of metal complex and preparation method thereof of double cup [4] arene derivatives, double cup [4] aromatic hydrocarbons Derivative has the molecular structure as shown in Formulas I -4；Double cup [4] arene derivatives and rare earth ion Tb3+Matched Object is closed, molecular structure is as shown in Formula II -4:
With intermediate E -4 and intermediate F-4 synthetic intermediate I ' -4, double cup [4] aromatic hydrocarbons are obtained after the oxidation of intermediate compound I ' -4 Derivative I -4, double cup [4] arene derivatives I-4 complex rare-earth metal ion Tb3+, obtain double cup [4] arene derivatives I-4 with Tb3+Complex II-4, synthetic route are as follows:
(1) preparation of intermediate E -4
Step 1: following intermediate Es -2 is made with the synthetic method of the intermediate E -2 of embodiment 3:
Step 2: intermediate E -2 (0.6mmol) being dissolved in the acetonitrile of 50mL, appropriate trifluoroacetic acid is added, is then added 4- (2,5- dioxo -1- pyrrolidinyl) benzoic acid (1.2mmol), flow back 12h, removes solvent, and purifying obtains intermediate E -4:
(2) preparation of intermediate F-4
Intermediate F-4 is equal to intermediate shown in formula F-2, and synthetic method is shown in the synthetic method in embodiment 3.
(3) preparation of intermediate compound I ' -4
Intermediate E -4 (1.04mmol) and potassium carbonate (5.2mmol) are dissolved in acetonitrile, then intermediate is added in stirring 2h F-4 (0.8mmol) flows back 5 days at 77 DEG C, and vacuum pump removes solvent, and the solid ethanol-water mixture of 1:1 is dissolved, hanged Turbid heated overnight at reflux, is then filtered while hot, and crude product is dissolved in 50mL chloroform, is then obtained by filtration with filter paper limpid molten Liquid, is then added the acetone of 40mL, intermediate compound I is precipitated to obtain in crystal ' -4, yield 65%:
(4) double cup [4] arene derivatives I-4, double cups [4] arene derivatives I-4 and Tb3+Complex II-4 preparation
Intermediate compound I ' -4 are dissolved in acetonitrile, suitable trifluoroacetic acid (TFA) are added, reaction 2h is stirred at room temperature, filter, remove Solvent crosses isolated double cup [4] the arene derivatives I-4 of pillar.Double cup [4] arene derivatives I-4 are dissolved in acetonitrile, and argon gas is protected Under the conditions of shield, a certain amount of TbCl is added into the 100mL two mouth flask of dehydration and deoxidation3With the processed acetonitrile of dehydration and deoxidation, TbCl3Molar ratio with compound I-1 is 1.4:1, cooling after 77 DEG C of reflux half an hours, filtering, HPLC isolatedization Close object double cup [4] arene derivatives I-4's and Tb3+Complex II-4:
The nuclear-magnetism characterize data of compound I-4:1H-NMR(CDC13) 8.06 (s, 2H, NH), 7.73-7.40 (m, 28H, Ar), 6.89 (m, 8H, CH2), 4.36 (d, 16H, PhOCH2CH2), 3.81 (s, 16H, PhCH2)。
Embodiment 8
The present embodiment provides the synthetic methods of the metal complex II-4 of double cup [4] arene derivatives a kind of:
With intermediate E -4, intermediate E ' -4 (being equal to intermediate A -1) and TsO-CH2-CH2- OsT synthetic intermediate I '- 4, obtain double cup [4] arene derivatives I-4 after the oxidation of intermediate compound I ' -4, double cup [4] arene derivatives I-4 complex rare-earth metals from Sub- Tb3+, obtain double cup [4] arene derivatives I-4 and Tb3+Complex II-4, synthetic route are as follows:
(1) preparation of intermediate E -4
Synthesis of the synthesis process with the intermediate E -4 of the present embodiment 7.
(2) preparation of intermediate E ' -4
Intermediate E ' -4 and intermediate E -1 are same compound, and synthesis process is the same as embodiment 1.
(3) preparation of intermediate compound I ' -4
By intermediate E -1 (1.1mmol), intermediate E ' -1 (0.8mmol) and K2CO3(6.5mmol) is dissolved in toluene, so After TsO-CH is added2-CH2- OsT (0.8mmol), under nitrogen protection, flow back 2h at a temperature of 115 DEG C, is then added certain The polyethylene glycol of amount, then flow back 2 days, cooling, the isolated intermediate compound I of silicagel column ' -4, yield 61%:
(3) double cup [4] arene derivatives I-4, double cups [4] arene derivatives I-4 and Tb3+Complex II-2 preparation
Synthesis process is the same as the present embodiment 7.
Embodiment 9
The present embodiment provides a kind of fluorescent probe molecules, wherein fluorescent marker is the double cups [4] prepared in embodiment 1 Arene derivatives and Te3+The complex II-1 of formation, biomolecule are EGFR antibody (E1282 is purchased from Merck).
EGF-R ELISA EGFR (Epidermal Growth Factor Receptor, EGFR) is ErbB receptor One kind of family is a kind of glycoprotein, belongs to tyrosine kinase receptor, cell membrane perforation, molecular weight 170KDa.EGFR is located at Cell membrane surface, after activating EGF and TGF (transforming growth factor) activation with ligand binding, EGFR is by list Body activates it to be located at intracellular kinase pathway after being converted into dimer, guidance downstream (including MPAK, Akt and JNK access) Phosphorylation, induced cell proliferation.Research shows that high expression or unconventionality expression in many entity tumors there are EGFR, EGFR with The proliferation of tumour cell, angiogenesis, tumor invasion, transfer and the inhibition of Apoptosis are related.The overexpression of EGFR is pernicious It plays an important role in the development of tumour, in the tissue such as kidney, lung cancer, prostate cancer, cancer of pancreas, breast cancer and spongiocytoma all There is the overexpression of EGFR.The expression degree of EGFR and the generation, development and transfer of tumour have close correlation, swollen It is of great significance in the clinical diagnosis and treatment of tumor.
Complex II-1 label EGFR antibody preparation method the following steps are included:
(1) suitable 1- ethyl -3- (3- dimethyl aminopropyl)-carbodiimides (EDC) and suitable N- hydroxyl are weighed Succinimide (NHS), is dissolved in respectively in the PBS buffer solution of 0.01M, and preparation obtains the NHS solution and 10mg/mL of 10mg/mL EDC solution.
(2) the complex II-1 of 5mg is weighed, the PBS buffer solution of 1mL is added thereto, complex II-1 is dissolved, is matched Close object II-1 solution.
(3) it is slowly added to EDC solution in complex II-1 solution obtained in step (2), shakes up reaction at room temperature 15min, the mass ratio that wherein complex II-1 and EDC are used are 1:2.
(4) NHS solution is added in the solution into step (3) after reaction, reacts 30min after mixing at room temperature, is lived The complex II-1 of change, the mass ratio that wherein complex II-1 and NHS are used are 1:4.
(5) into the complex II-1 solution after activation be added 30mg/mL EGFR antibody-solutions, complex II-1 with The mass ratio that EGFR antibody uses is 20:1, room temperature cross-linking reaction 16 hours on blending instrument.
(6) after reaction, reaction solution is dialysed at 4 DEG C 8h (changing liquid 4 times) with the PBS buffer solution of 0.01M, is collected, Obtain the EGFR antibody of complex II-1 label, -20 DEG C of preservations.
As alternative embodiment, the fluorescent marker for forming fluorescent probe molecule can also be II-2~II-51 The complex of double cups [4] arene derivatives and rare earth ion of structure shown in any.
Experimental example 1
1, experiment purpose: the fluorescence spectrum of the metal complex of double cup [4] arene derivatives and rare earth ion is detected.
2, experimental method:
(1) dimethyl sulfoxide stock solution (10 μ g/mL, 1mL), three hydroxyls of complex II-1 are added in 10.0mL volumetric flask Aminomethane-hydrochloric acid (Tris-HCl) buffer solution (1X10-3Mol/L, 1mL) and distilled water (3mL), use dimethyl sulfoxide Solution is diluted to scale, shakes up, and is placed at room temperature for l0min, moves into quartz colorimetric utensil (the Cary Eclipse fluorescence spectrophotometer light of lcm Degree meter, VARIAN company, the U.S.) carry out fluorescence spectrometry.
(2) in method shown in step (1), the fluorescence spectrum of complex II-2, II-3 and II-4 are measured respectively.
3, experimental result:
Fig. 2~Fig. 4 shows complex II-1~complex II-4 fluorescence spectrum testing result.In the light by specific wavelength After excitation, complex II-1~complex II-4 can generate apparent light absorption, then emit fluorescence, and wherein Fig. 2, which is shown, matches The fluorescence spectrum of object II-1 is closed, Fig. 3 shows that the fluorescence spectrum of complex II-2, Fig. 4 show the fluorescence spectrum of complex II-3, figure The fluorescence spectrum of 5 display complex II-4.The signal stabilization of complex II-1~complex II-4 fluorescent emission, can form spy Determine the fluorescence emission spectrum of peak shape, and the peak value of fluorescence emission peak is high, double cups [4] arene derivatives pair of structure shown in formula I Tb in rare earth ion3+And Eu3+With highly selective fluorescence signal energy transmission, to generate strong fluorescence signal Response is suitable for detection of the biomolecule such as luminescent dye molecule labeling nucleic acid, albumen for field of biomedicine.It is above-mentioned to match It closes object II-1~complex II-4 fluorescence exciting wavelength and launch wavelength statistics is as shown in table 1:
Table 1
Fluorescent molecule Excitation wavelength (nm) Maximum emission wavelength (nm)
Complex II-1 298 550
Complex II-2 299 620
Complex II-3 299 620
Complex II-4 298 550
Experimental example 2
1, experiment purpose: the metal complex for detecting double cup [4] arene derivatives (complex II-1, complex II-2, is matched Close object II-3 and complex II-4) cytotoxicity.
2, experimental method:
(1) metal complex of double cups [4] arene derivatives of various concentration is prepared
PC-3 cell strain (Human Prostate Cancer Cells) is put into 96 orifice plates and is cultivated.With DMSO (dimethyl sulfoxide) point Shellfish prepares complex II-1, complex II-2, complex II-3 and the complex II-4 of 40mg/mL, then matching 40mg/mL Close object II-1~complex II-4 solution respectively be free of serum DMEM in high glucose culture solution be diluted to 30 μ g/mL, 60 μ g/mL, The solution of 120 μ g/mL, 300 μ g/mL, 600 μ g/mL and 1200 μ g/mL, and be placed under conditions of temperature is 4 DEG C and save.To 96 After cell in orifice plate is adherent, take respectively the above-mentioned solution prepared of 10 μ L be put in containing 90 μ L serum-containing mediums 96 (the calixarenes fluorescent chemicals concentration of the present invention in hole is respectively 3 μ g/mL, 6 μ g/mL, 12 μ g/mL, 30 μ for culture in orifice plate G/mL, 60 μ g/mL and 120 μ g/mL).
(2) cell culture
PC-3 cell adherent growth can be passed on to 90~95%.In superclean bench, inhales and abandon in above-mentioned 96 orifice plate Culture solution, then rinse is carried out to the attached cell in 96 orifice plates with PBS (phosphate buffer) of the 2mL after high pressure degerming, so 1mL trypsase (0.25%Trypsin-EDTA of gibco company production) is added afterwards to carry out the attached cell in 96 orifice plates Digestion is added immediately 2mL culture solution and terminates digestion, then use after being observed under the microscope to most cells diminution change after circle Centrifuge tube is drawn 15mL and through postdigestive cell liquid and is put it into centrifuge, carries out 5 points of centrifugation with the revolving speed of 1000r/min Clock.After removing supernatant, 1mL culture solution is added, then the cell of bottom precipitation is broken up and is formed uniformly cell suspension.It draws 400 μ L cell suspensions, which are put into another culture vessel, to be cultivated, and is in addition drawn 100 μ L cell suspensions again and is put in cell counting board Number number, being then diluted to 500 μ L cell suspensions of remainder makes its density reach 5.6*104/ mL, and the cell after dilution is hanged Liquid, which is inoculated in 3 piece of 96 orifice plate (90 μ L cell suspensions are added in every hole), to be continued to cultivate.
(3) MTT is tested
The cell growth condition that next day is observed in 96 orifice plates is separately added into 10 μ L (30 μ g/mL), 10 μ after cell is adherent The sheet of L (60 μ g/mL), 10 μ L (120 μ g/mL), 10 μ L (300 μ g/mL), 10 μ L (600 μ g/mL) and 10 μ L (1200 μ g/mL) Invention compound and DMEM in high glucose culture solution without serum are in hole.MTT (3- (4,5- dimethylthiazole -2) -2,5- hexichol Base tetrazole bromide) it is dissolved in formation MTT solution in PBS (phosphate buffer).After culture 1,2,3 day, add respectively in hole Enter 10 MTT solution of the μ L (5mg/mL) through filtration sterilization, after continuing culture 4 hours, inhales and abandon waste liquid in hole, 150 μ L are added in every hole DMSO (dimethyl sulfoxide) solution places shaking table (the TS-2 shaking table of its woods Bell's instrument manufacturing Co., Ltd production) shimmy Amplitude is rocked 20 minutes under conditions of being 70Rpm, finally with enzyme-linked immunosorbent assay instrument (the Epoch system of Bai Teng instrument company production Column) absorbance value is measured at 490nm wavelength, data are recorded, it is dense with the metal ion match of double cups [4] arene derivatives Degree is abscissa, and cell viability is that ordinate draws histogram.
3, experimental result:
Fig. 6 shows influence of the complex II-1 of various concentration to prostate gland cancer cell PC-3 growth activity, and Fig. 7 is shown not With influence of the complex II-2 to prostate gland cancer cell PC-3 growth activity of concentration, Fig. 8 shows the complex II- of various concentration The influence of 3 pairs of prostate gland cancer cell PC-3 growth activities, Fig. 9 show the complex II-4 of various concentration to prostate gland cancer cell The influence of PC-3 growth activity.By result in figure it is found that in the control of complex concentration when within 30 μ g/mL, complex II-1 ~complex II-4 inhibits cell growth without obvious；When complex concentration is 60 μ g/mL, the growth vigor of cell is still protected It holds 60% or more, illustrates that the cytotoxicity of the metal ion match of double cups [4] arene derivatives provided by the invention is low, fit Close the detection being applied in active somatic cell.
Experimental example 3
1, experiment purpose: the glimmering of the metal complex II-1 coupling EGFR antibody formation of double cup [4] arene derivatives is detected Fluorescence imaging of the light probe in cell.
2, experimental method:
(1) in 6 well culture plates preset 25mm coverslip, the PC-3 cell of logarithmic growth phase, be inoculated in 6 holes culture In plate, using human embryonic kidney cells 293T as negative control, then in 5%CO2, 37 DEG C be incubated for, cultivate 48h；
(2) after having cultivated cell in culture plate, culture medium is absorbed, using PBS buffer solution fine laundering cell 3 times, every time 5min；
(3) PBS buffer solution is sucked, 4% paraformaldehyde (PBS preparation) room temperature is added and fixes 20 minutes；
(4) PBS containing 4% paraformaldehyde is sucked, is rinsed cell 3 times using PBS buffer solution, each 5min；
(5) PBS is sucked, 0.5%Triton X-100 (PBS preparation) the penetrating 20min of room temperature is used；
(6) Triton X-100 is removed, is rinsed cell 3 times using PBS, each 5min；
(6) PBS is sucked, the serum (PBS preparation) homologous with EGFR antibody of 10% volume fraction is added dropwise on the cover slip Room temperature closes half an hour；
(7) confining liquid is removed, does not wash, the complex II- of enough (1:200) volume dilutions is added dropwise into every coverslip The EGFR antibody-solutions (1mg/mL) of 1 label, are then placed in 4 DEG C of overnight incubations (or 37 DEG C, 60min) in wet box；
(8) the EGFR antibody of complex II-1 label is removed, PBST (1*PBS, contain 1 ‰ Tween20) embathes 3 times, every time 5min；
(9) it redyes core: 0.5 μ g/ml DAPI is added dropwise, be protected from light and be incubated for 5min, core dye is carried out to sample；
(10) PBST (1*PBS contains 1 ‰ Tween-20) embathes 3 times, each 5min；
(11) mounting liquid of the droplet containing anti-fluorescence quenching is dripped on glass slide, coverslip is taken out from hole, blotting paper Surplus liquid is blotted, faces on lower cover to mounting liquid, touches it gently on glass slide；Slide, which is placed in dark place 5min, makes it It dries, in fluorescence microscopy microscopic observation and acquires image.
3, experimental result:
Figure 10 is shown with the knot of the EGRF expression in the EGFR antibody test PC-3 cell and 293T of complex II-1 label Fruit figure.By Figure 10 result it is found that with the PC-3 cell after fluorescent probe molecule (complex II-1 modifies EGFR antibody) incubation Afterwards, apparent green fluorescence is able to detect that in PC-3 cell, fluorescence intensity is significantly stronger than 293T cell.Complex II-1 mark The penetrability of the EGFR antibody on cell film of note is good, and fluorescence intensity is high, can specifically bind overexpression in cancer cell EGFR albumen.There is apparent fluorescence, complex II-1 coupling after using complex II-1 as conjugated fluorescent dyes biomolecule Biomolecule have fluorescence imaging it is good, detection high specificity and high sensitivity advantage, be suitable for basic scientific research and The fields such as clinical medicine detection.
Experimental example 4
1, experiment purpose: the metal complex II-1 coupling EGFR antibody for measuring double cup [4] arene derivatives forms fluorescence The detection of probe molecule limits.
2, experimental method:
(1) fluorescent probe molecule is fixed on ELISA Plate surface
A. 96 hole elisa Plates of polystyrene or polypropylene material are selected, ELISA Plate is rinsed using preceding with PBS buffer solution, so The fluorescent probe molecule prepared in embodiment 5 is diluted to 3~10 μ g/mL afterwards, is added in ELISA Plate；
B. it covers diaphragm plate and is coated with 4 DEG C, place 6-24 hours；Then coating buffer is discarded, washs 3 times with PBST cleaning solution, gently Clapping ELISA Plate dries cleaning solution；
C. the BSA confining liquid sealing plate that 200 μ l mass fractions are 1% is added into every hole of ELISA Plate, in 37 DEG C of placement 1-2 Hour；
D. the solution inside orifice plate is got rid of, is patted dry after washing 2 times with PBST, 4 DEG C is placed in and saves backup.
(2) EGFR albumen is formulated as various concentration with PBS buffer solution, is added separately to be fixed with the enzyme mark of EGFR albumen In the different holes of plate, it is incubated for two hours at 37 DEG C, combines it sufficiently, then removes fluorescence probe solution, washed with PBST Wash 3 times, using microplate reader detect in different holes fluorescence intensity (instrument condition: excitation wavelength: 550nm, scanning range: 200~ 700nm, PMT Voltage:700V, EXSlit:5.0nm), using PBS buffer as blank sample solution.
(3) standard curve that different antibodies concentration corresponds to the linear fit of EGFR detection fluorescent intensity is drawn, with [LoD= The slope of (standard deviation of 3X blank value)/linear fit] come calculate detection limit (LoD).
3, experimental result:
EGFR protein concentration changes in 4.2x 10-1~9.3x 102In the range of μ g/mL, it is dense that EGFR albumen can be obtained Spend the linearity curve of corresponding fluorescent probe molecule fluorescence intensity, the sky that the standard deviation of blank value passes through 10 batches of measurement White sample solution is measured, and the detection of the EGFR antibody test EGFR albumen of complex II-1 label is obtained by linearity curve As shown in table 2, it is 3.2x 10 that fluorescent probe molecule is adapted to detect for minimum concentration to limit-2The protein molecular of μ g/mL, probe molecule Detection limit it is low, detection high sensitivity.
Table 2
The range of linearity (μ g/mL) Related coefficient Detection limit (μ g/mL)
Fluorescent probe molecule 4.2x 10-1~9.3x 102 0.996 3.2x 10-2
Experimental example 5
1, experiment purpose: the metal complex (complex II-1~II-4) of double cup [4] arene derivatives is detected in cell In fluorescent stability.
2, experimental method:
(1) by PC-3 cell in 5%CO2, temperature is culture in 37 DEG C of incubator to logarithmic phase；
(2) complex II-1, complex II-2, complex II-3 and complex II-4 are dissolved in dimethyl sulphoxide solution Making its concentration is respectively 1mg/mL；
(3) the PC-3 cell of logarithmic growth phase, is inoculated in 6 well culture plates, and cell culture is to covering single culture hole 60%~70% area；
(4) culture medium in culture plate is removed, 1.0mL is added, the sterilizing PBS buffer solution of pH=7.4 is washed once.So Complex II-1~II-3 solution of 10 μ l and the cell culture medium of 1.9mL are separately added into single cell culture well afterwards. Continue to cultivate cell, has the culture plate of complex II-1~II-4 in culture 12h, for 24 hours with taking out to be incubated for respectively when 48h, will train The solution supported in hole is sucked out, and is carefully cleaned three times with PBS buffer solution.Then shoot fluorescence photo.
3, experimental result:
Figure 11, which is shown, carries out cell dyeing fluorescence intracellular after cultivating different time with complex II-1~II-4 Strength Changes result.Lateral first row successively show from left to right with complex II-1 culture 12h, for 24 hours with fluorescence when 48h at As situation, lateral second row successively shows from left to right with complex II-2 culture 12h, for 24 hours with fluorescence imaging feelings when 48h Condition, lateral third row is successively shown from left to right with complex II-3 culture 12h, for 24 hours with fluorescence imaging situation when 48h, horizontal To the 4th row successively show from left to right with complex II-4 culture 12h, for 24 hours with fluorescence imaging situation when 48h.By Figure 11 As a result it is found that in the cell dyed with complex II-1~II-4, apparent intracellular Fluorescence imaging can be detected, it is glimmering Luminous intensity is high, and invention does not occur because of the addition of complex and changes for cellular morphology, illustrates complex II-1~II-4 conduct The fluorescent quantum rate of luminescent dye molecule is high, cell membrane penetration is high, and good biocompatibility.With the increasing of cell culture time Add, significant change, the complex that double cup [4] arene derivatives and rare earth ion are formed do not occur for intracellular fluorescence intensity Stable fluorescence can be provided within 48 hours, and fluorescent stability is high, fluorescence lifetime is long.
Obviously, the above embodiments are merely examples for clarifying the description, and does not limit the embodiments.It is right For those of ordinary skill in the art, can also make on the basis of the above description it is other it is various forms of variation or It changes.There is no necessity and possibility to exhaust all the enbodiments.And it is extended from this it is obvious variation or It changes still within the protection scope of the invention.

Claims (14)

1. a kind of metal complex of double cups [4] arene derivatives, which is characterized in that have the structure as shown in Formula II:
Wherein, M is rare earth ion；
R1~R8Separately it is selected from-H ,-NH2、-COOH、-CH2COOH、-CONH(CH2)XNH2、-CONH2、-SH、- CH2SH、-SO3H、-SO3R、-NHCO(CH2)XCOOH、-NO2、-CH2PO(OH)2、
R is alkali metal or benzene, R1~R8It is not simultaneously-H, the integer that X is 0~3；
A is selected from-(CH2-CH2)n-、-(CH2OCH2)n-、-CONH(CH2)nNHCO- andN is 1~3 Integer.
2. the metal complex of double cups [4] arene derivatives according to claim 1, which is characterized in that the rare earth gold Belong to is terbium or europium.
3. the metal complex of double cups [4] arene derivatives according to claim 2, which is characterized in that double cups [4] The metal complex of arene derivatives is selected from following structures:
4. a kind of synthetic method of the metal complex of double cup [4] arene derivatives described in claim 1, which is characterized in that The following steps are included:
(1) cup [4] arene compounds shown in cup [4] arene compounds shown in formula E and formula E ' are synthesized；Shown in formula E ' For cup [4] arene compounds through condensation reaction, introducing-O-A- group obtains intermediate shown in formula F '；
Wherein, R1'~R8' separately it is selected from-CHO ,-CH2CHO、-NHCO(CH2)XCHO、-SO3R、-H、-NH2、-CONH (CH2)XNH2、-CONH2、-SH、-CH2SH、-NO2、-CH2PO(OH)2、R is alkali gold Category or benzene, the integer that X is 0~3, R1'~R8' it is not simultaneously-H；
TsO- is p-methyl benzenesulfonic acid base；
(2) intermediate shown in formula F ' is dissolved in the first organic solvent, p-methyl benzene sulfonic chloride is added, is reacted at 0~4 DEG C, Reaction solution is poured into acid after reaction, precipitating, cup [4] arene compounds shown in as formula F are precipitated；
(3) [4] arene compounds of cup shown in formula E and alkali metal salt are dissolved in the second organic solvent, are added shown in F after mixing Cup [4] arene compounds, then it is organic to be changed to third second organic solvent by the back flow reaction at 75~80 DEG C Solvent continues back flow reaction, filters after reaction, and the crystal in filtrate is precipitated；
(4) work as R1'~R8' it does not include-CHO ,-CH2CHO、-NHCO(CH2)XCHO and-SO3When R, crystal obtained in step (3) As double cup [4] arene derivatives shown in Formulas I；
Work as R1'~R8' in include at least one-CHO ,-CH2CHO、-NHCO(CH2)XCHO and/or-SO3When R, system in step (3) Crystal be intermediate shown in Formulas I ' shown in intermediate, by Formulas I ' after peroxidating and/or hydrolysis, be made shown in Formulas I Double cups [4] arene derivatives；
(5) in an inert atmosphere, after rare earth metal salt being mixed with the 4th organic solvent that dehydration and deoxidation is handled 75~ It flows back at 80 DEG C, double cup [4] arene derivatives shown in Formulas I is then added, continue back flow reaction, after reaction cooling reaction Product filters, the metal complex of double cup [4] arene derivatives shown in isolated Formula II；
Synthetic route is as follows:
5. a kind of synthetic method of the metal complex of double cup [4] arene derivatives described in claim 1, which is characterized in that The following steps are included:
S1. cup [4] arene compounds shown in cup [4] arene compounds shown in formula E and formula E ' are synthesized；Wherein, R1'~ R8' separately it is selected from-CHO ,-CH2CHO、-NHCO(CH2)XCHO、-SO3R、-H、-NH2、-CONH(CH2)XNH2、- CONH2、-SH、-CH2SH、-NO2、-CH2PO(OH)2、R is alkali metal or benzene, and X is 0~3 integer, R1'~R8' it is not simultaneously-H；
S2. cup [4] arene compounds shown in cup shown in formula E [4] arene compounds, formula E ' and alkali metal salt are mixed It is even, it is dissolved in the 5th organic solvent, continuously adds compound TsO-A-OsT, under inert gas protection, next time at 110-125 DEG C Stream reaction, cooled reaction solution, post separation obtain reaction product after reaction；Wherein, TsO- is p-methyl benzenesulfonic acid base；
S3. work as R1'~R8' it does not include-CHO ,-CH2CHO、-NHCO(CH2)XCHO and-SO3When R, reaction obtained in step S2 Product is intermediate shown in Formulas I；
Work as R1'~R8' in include at least one-CHO ,-CH2CHO、-NHCO(CH2)XCHO and/or-SO3When R, made in step S2 Reaction product be intermediate shown in Formulas I ' shown in intermediate, by Formulas I ' after peroxidating and/or hydrolysis, Formulas I is made Shown in double cup [4] arene derivatives；
S4. in an inert atmosphere, after rare earth metal salt being mixed with the 4th organic solvent that dehydration and deoxidation is handled 75~ It flows back at 80 DEG C, double cup [4] arene derivatives shown in Formulas I is then added, continue back flow reaction, after reaction cooling reaction Product filters, the metal complex of double cup [4] arene derivatives shown in isolated Formula II；
Synthetic route is as follows:
6. synthetic method according to claim 4, which is characterized in that first organic solvent be pyridine, described second Organic solvent is acetonitrile, and the third organic solvent is that second alcohol and water is organic with the mixed solution of the volume ratio of 1:1, the described 4th Solvent is acetonitrile, and the alkali metal salt is potassium carbonate.
7. synthetic method according to claim 5, which is characterized in that the 5th organic solvent is toluene.
8. the synthetic method according to claim 4 or 6, which is characterized in that cup [4] aromatic hydrocarbons chemical combination shown in the formula E The molar ratio of object and cup [4] arene compounds shown in the formula F is 3:2~1:1, double cup [4] aromatic hydrocarbons shown in the Formulas I The molar ratio of derivative and the rare earth metal salt is 1:1~2:3, cup [4] arene compounds shown in the formula E with it is described The molar ratio of alkali metal salt is 1:5.
9. the synthetic method according to claim 5 or 7, which is characterized in that cup [4] aromatic hydrocarbons chemical combination shown in the formula E The molar ratio of cup [4] arene compounds, the compound TsO-A-OsT and the alkali metal salt shown in object, the formula E ' For (2~3): (2~3): (2.5~3): (12.5~20).
10. use of the metal complex of described in any item double cup [4] arene derivatives of claim 1-3 as fluorescent dye On the way.
11. a kind of fluorescent probe molecule, the fluorescent probe molecule is the biomolecule of fluorochrome label, which is characterized in that The fluorescent dye is the metal complex of described in any item double cup [4] arene derivatives of claim 1-3, the biology point Son is selected from least one of amino acid, polypeptide, albumen, nucleotide, oligonucleotides and nucleic acid.
12. fluorescent probe molecule according to claim 11, which is characterized in that the nucleotide, oligonucleotides and nucleic acid For amido modified nucleotide, oligonucleotides and nucleic acid.
13. fluorescent probe molecule according to claim 11 or 12, which is characterized in that double cup [4] arene derivatives Metal complex in the presence of bridging agent, be connected with any group in the amino of the biomolecule, carboxyl and sulfydryl.
14. fluorescent probe molecule according to claim 13, which is characterized in that the bridging agent is that N- hydroxysuccinimidyl acyl is sub- Amine, N- hydroxy thiosuccinimide salt, maleimide, glutaraldehyde or carbodiimide.
CN201810215041.0A 2018-03-15 2018-03-15 The metal complex and its synthetic method of double cup [4] arene derivatives and application Active CN108314690B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810215041.0A CN108314690B (en) 2018-03-15 2018-03-15 The metal complex and its synthetic method of double cup [4] arene derivatives and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810215041.0A CN108314690B (en) 2018-03-15 2018-03-15 The metal complex and its synthetic method of double cup [4] arene derivatives and application

Publications (2)

Publication Number Publication Date
CN108314690A CN108314690A (en) 2018-07-24
CN108314690B true CN108314690B (en) 2019-06-07

Family

ID=62902221

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810215041.0A Active CN108314690B (en) 2018-03-15 2018-03-15 The metal complex and its synthetic method of double cup [4] arene derivatives and application

Country Status (1)

Country Link
CN (1) CN108314690B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109799159B (en) * 2019-02-25 2021-05-28 重庆大学 MOFs material modified chloroform gas QCM sensor
CN110174386B (en) * 2019-06-11 2021-11-23 青岛科技大学 Host-guest sensor pair for detecting spermine and application thereof
CN114652849B (en) * 2022-03-22 2023-11-17 南开大学 Preparation method and application of calixarene modified albumin capable of simultaneously delivering multiple medicines and accurately regulating and controlling medicine proportion

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07206852A (en) * 1994-01-25 1995-08-08 Res Dev Corp Of Japan Calixarene derivative
EP0705241B1 (en) * 1993-06-23 1999-01-13 Radiometer Medical A/S Calix(4)Arenes
KR100241087B1 (en) * 1997-10-07 2000-03-02 김성년 Calix[4]arene dibenzo crown ethers removing cesium ion selectively and process for preparation thereof
CN105884585A (en) * 2016-05-16 2016-08-24 山东大学（威海） Method for preparing calix[4]arene fluorescent dye with solid light emission property
CN106800568A (en) * 2017-01-19 2017-06-06 东北师范大学 Eight carboxyls cup [4] aromatic hydrocarbons europium metal complex and its preparation method and application
CN106810581A (en) * 2016-12-20 2017-06-09 谢长江 A kind of thio cup [4] aromatic hydrocarbons Schiff base Binuclear Cobalt complex and its synthetic method and application
CN107043364A (en) * 2016-02-05 2017-08-15 徐州医学院 Oxa- cup [4] arene derivatives and its application
CN107365291A (en) * 2017-08-11 2017-11-21 扬州大学 Oxa- cup [4] aromatic hydrocarbons list schiff bases, synthetic method and its application in copper ion identification

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297395B1 (en) * 1995-11-10 2001-10-02 The Secretary Of State For Defence In Her Brittanic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Calixarenes and their use for sequestration of metals

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0705241B1 (en) * 1993-06-23 1999-01-13 Radiometer Medical A/S Calix(4)Arenes
JPH07206852A (en) * 1994-01-25 1995-08-08 Res Dev Corp Of Japan Calixarene derivative
KR100241087B1 (en) * 1997-10-07 2000-03-02 김성년 Calix[4]arene dibenzo crown ethers removing cesium ion selectively and process for preparation thereof
CN107043364A (en) * 2016-02-05 2017-08-15 徐州医学院 Oxa- cup [4] arene derivatives and its application
CN105884585A (en) * 2016-05-16 2016-08-24 山东大学（威海） Method for preparing calix[4]arene fluorescent dye with solid light emission property
CN106810581A (en) * 2016-12-20 2017-06-09 谢长江 A kind of thio cup [4] aromatic hydrocarbons Schiff base Binuclear Cobalt complex and its synthetic method and application
CN106800568A (en) * 2017-01-19 2017-06-06 东北师范大学 Eight carboxyls cup [4] aromatic hydrocarbons europium metal complex and its preparation method and application
CN107365291A (en) * 2017-08-11 2017-11-21 扬州大学 Oxa- cup [4] aromatic hydrocarbons list schiff bases, synthetic method and its application in copper ion identification

Also Published As

Publication number Publication date
CN108314690A (en) 2018-07-24

Similar Documents

Publication Publication Date Title
CN108314690B (en) The metal complex and its synthetic method of double cup [4] arene derivatives and application
He et al. Sensing and intracellular imaging of Zn2+ based on affinity peptide using an aggregation induced emission fluorescence “switch-on” probe
Li et al. A near-infrared fluorescent probe for Cu2+ in living cells based on coordination effect
EP1350102A2 (en) Detection of analytes
CN112209871B (en) Zinc ion fluorescent probe based on tetraphenylethylene and preparation method and application thereof
Yang et al. Organic nanostructure-based probes for two-photon imaging of mitochondria and microbes with emission between 430 nm and 640 nm
CN112062755B (en) Near-infrared fluorescent molecular probe for detecting aspartyl aminopeptidase, preparation method and application
CN112142721B (en) Near-infrared two-region thiopyran salt fluorescent compound capable of targeting mitochondria and preparation method and application thereof
US8779165B2 (en) Fluorescent ion indicators and their applications
CN108329336A (en) The metal complex and its synthetic method of double cup [4] arene derivatives and application
US20150079625A1 (en) Naphthalene-based two-photon fluorescent probes, preparation method and use thereof
JP3810260B2 (en) Method for determination of triaza-cryptands and alkali ions
Diwan et al. A water compatible turn ‘on’optical probe for Cu2+ based on a fluorescein–sugar conjugate
EP0894261A1 (en) Covalently immobilized fluoroionophores as optical ion sensors
Karakuş et al. A guanidinium modified rhodamine-based fluorescent probe for in vitro/vivo imaging of gold ions
Du et al. Development of bi-oligo (ethylene glycol)-functionalized fluorescent probe for two-photon and noninvasive imaging in Arabidopsis thaliana
CN114195774A (en) Photosensitizer with hypochlorous acid activated fluorescence and mitochondrion targeting functions and preparation method and application thereof
CN114539183A (en) Lipid drop targeting and biological thiol sensitive fluorescent probe for cancer cell tissue diagnosis, preparation and application
CN108395372B (en) The metal complex and its synthetic method of double cup [4] arene derivatives and application
CN109456250A (en) Hot activation delayed fluorescence (TADF) nano-probe and preparation method thereof and the application in bio-imaging
CN108752275A (en) A kind of pH fluorescence probes and its preparation method and application
CN107118206A (en) The pyridine derivate Zn of one class quinoline two2+Fluorescence probe and its application
CN108586502A (en) The metal complex and its synthetic method of double cup [4] arene derivatives and application
CN112250700B (en) BODIPY (boron dipyrromethene) protein misfolding probe Halo-BODIPY as well as preparation method and application thereof
Yang et al. Dual-lifetime luminescent probe for time-resolved ratiometric oxygen sensing and imaging

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20190809

Address after: Science and Technology City kolding road high tech Zone of Suzhou City, Jiangsu Province, No. 88 215163

Co-patentee after: SUZHOU INSTITUTE OF BIOMEDICAL ENGINEERING AND TECHNOLOGY, CHINESE ACADEMY OF SCIENCES

Patentee after: Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences

Address before: Science and Technology City kolding road high tech Zone of Suzhou City, Jiangsu Province, No. 88 215163

Patentee before: Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences

CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: Science and Technology City kolding road high tech Zone of Suzhou City, Jiangsu Province, No. 88 215163

Co-patentee after: Suzhou Guoke medical technology development (Group) Co., Ltd

Patentee after: Suzhou Institute of Biomedical Engineering and Technology Chinese Academy of Sciences

Address before: Science and Technology City kolding road high tech Zone of Suzhou City, Jiangsu Province, No. 88 215163

Co-patentee before: SUZHOU GUOKE MEDICAL TECHNOLOGY DEVELOPMENT Co.,Ltd.

Patentee before: Suzhou Institute of Biomedical Engineering and Technology Chinese Academy of Sciences